A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens
Clinical trial NCT02354586 · COMPLETED
Trial details
- NCT number
- NCT02354586
- Sponsor
- Tesaro, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-23
- Primary completion
- 2018-02-28
- Enrollment
- 463
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.